Gimv

Gimv company information, Employees & Contact Information

Explore related pages

Related company profiles:

Gimv is a European investment company with more than 40 years' experience in private equity. Listed on Euronext Brussels, Gimv currently has EUR 1.5 billion of assets under management. The portfolio contains around 60 portfolio companies, with a combined turnover of EUR 3.7 billion and more than 20,000 employees. As a recognized market leader in selected investment platforms, Gimv identifies entrepreneurial and innovative companies with high-growth potential and supports them in their transformation into market leaders. Gimv’s five investment platforms are: Consumer, Healthcare, Life Sciences, Smart Industries and Sustainable Cities. Each of these platforms works with a skilled and dedicated team across Gimv’s home markets of the Benelux, France and Germany and can count on an extended international network of experts. We are a strategic partner for ambitious companies wanting to grow into leaders in their sectors. We help them plan ways to speed up their expansion. We take a flexible approach based on our solid balance sheet, patient capital and long-term view. Hand-in-hand with growth companies, we are working on innovative solutions for tomorrow’s society. More information on Gimv can be found on www.gimv.com.

Company Details

Employees
177
Founded
-
Address
Karel Oomsstraat 37, Antwerp,2018,belgium
Phone
+32 3 290 21 00
Email
in****@****imv.com
Industry
Financial Services
NAICS
Finance and Insurance
Monetary Authorities-Central Bank
Website
gimv.com
HQ
Antwerp
Looking for a particular Gimv employee's phone or email?

Gimv Questions

News

Reed Smith advises private equity firm Gimv and E.GRUPPE on acquisition of LET Group - Reed Smith LLP

Reed Smith advises private equity firm Gimv and E.GRUPPE on acquisition of LET Group Reed Smith LLP

Gimv's Advanced CSRD- and ESRS-aligned ESG due diligence tool - PRI | Home

Gimv's Advanced CSRD- and ESRS-aligned ESG due diligence tool PRI | Home

Kurma and Gimv exit ImCheck Therapeutics in up to €1bn trade sale - EU.COM

Kurma and Gimv exit ImCheck Therapeutics in up to €1bn trade sale EU.COM

Gimv to take majority stake in Hemink - pehub.com

Gimv to take majority stake in Hemink pehub.com

Belgian PE investor Gimv acquires majority stake in The Spice Factory - Global Food Industry News

Belgian PE investor Gimv acquires majority stake in The Spice Factory Global Food Industry News

The Netherlands: Gimv takes majority stake in Novicare from Gilde Healthcare - Investors in Healthcare

The Netherlands: Gimv takes majority stake in Novicare from Gilde Healthcare Investors in Healthcare

Simmons supports PE firm GIMV on major German homecare merger - Simmons & Simmons

Simmons supports PE firm GIMV on major German homecare merger Simmons & Simmons

Gimv, PMV, Smartfin and SFPIM sell Itineris shares to Cobepa - EU.COM

Gimv, PMV, Smartfin and SFPIM sell Itineris shares to Cobepa EU.COM

Dutch CDMO BioConnection announces substantial investment by Gimv, supported by existing shareholders - PR Newswire

Dutch CDMO BioConnection announces substantial investment by Gimv, supported by existing shareholders PR Newswire

Onera raises over €30M in Series C funding - GlobeNewswire

Onera raises over €30M in Series C funding GlobeNewswire

Gimv creates new fund for life science companies - Labiotech.eu

Gimv creates new fund for life science companies Labiotech.eu

Gimv - Check Point Software

Gimv Check Point Software

Spineart raises CHF 25 million to accelerate global expansion and innovation - Greater Geneva Bern area

Spineart raises CHF 25 million to accelerate global expansion and innovation Greater Geneva Bern area

Gimv reports 3.4% NAV growth, portfolio return exceeds target - Investing.com

Gimv reports 3.4% NAV growth, portfolio return exceeds target Investing.com

Hexagon acquires Luciad from GIMV - Jones Day

Hexagon acquires Luciad from GIMV Jones Day

Hein Deprez Named New Greenyard CEO, Marleen Vaesen Steps Down - AndNowUKnow

Hein Deprez Named New Greenyard CEO, Marleen Vaesen Steps Down AndNowUKnow

Abingworth, Gimv and Pfizer back stealthy Swiss startup's $61M round to crack gene therapy delivery - Fierce Biotech

Abingworth, Gimv and Pfizer back stealthy Swiss startup's $61M round to crack gene therapy delivery Fierce Biotech

Germany: Gimv sells majority stake in rehaneo to Fremman Capital - Investors in Healthcare

Germany: Gimv sells majority stake in rehaneo to Fremman Capital Investors in Healthcare

With stacked to-do list, ImCheck checks off next funding round, refueling with about $101M - Fierce Biotech

With stacked to-do list, ImCheck checks off next funding round, refueling with about $101M Fierce Biotech

Can Gimv NV (GI3) stock retain market dominance - Weekly Stock Recap & Growth Focused Investment Plans - Trung tâm Dự báo KTTV quốc gia

Can Gimv NV (GI3) stock retain market dominance - Weekly Stock Recap & Growth Focused Investment Plans Trung tâm Dự báo KTTV quốc gia

Flemish government sells its stake in investment company Gimv - belganewsagency.eu

Flemish government sells its stake in investment company Gimv belganewsagency.eu

Can Gimv NV (GI3) stock retain market dominance - Quarterly Risk Review & Real-Time Stock Price Movement Reports - Trung tâm Dự báo KTTV quốc gia

Can Gimv NV (GI3) stock retain market dominance - Quarterly Risk Review & Real-Time Stock Price Movement Reports Trung tâm Dự báo KTTV quốc gia

Projective and Exellys team up with Gimv to turbocharge growth - Consultancy.eu

Projective and Exellys team up with Gimv to turbocharge growth Consultancy.eu

Martens Brewery acquires United Dutch Breweries - Food and Drink International

Martens Brewery acquires United Dutch Breweries Food and Drink International

Roland Berger advises Parcom on Climate for Life deal - Consultancy.eu

Roland Berger advises Parcom on Climate for Life deal Consultancy.eu

Main-backed Bizzdesign buys enterprise architecture software biz Mega from GIMV - pehub.com

Main-backed Bizzdesign buys enterprise architecture software biz Mega from GIMV pehub.com

Stibbe advises Alro Group - Stibbe

Stibbe advises Alro Group Stibbe

Gimv : Life Sciences realizes successful exit with the sale of its stake in Imcheck Therapeutics to Ipsen - MarketScreener

Gimv : Life Sciences realizes successful exit with the sale of its stake in Imcheck Therapeutics to Ipsen MarketScreener

Arcus buys European industrial temperature control equipment rental specialist - IPE Real Assets

Arcus buys European industrial temperature control equipment rental specialist IPE Real Assets

Variass partners with AME after Gimv investment - Bits&Chips

Variass partners with AME after Gimv investment Bits&Chips

Gimv Backs Alro Group - FinSMEs

Gimv Backs Alro Group FinSMEs

Gimv has Invested in Apraxon - Turkchem.net

Gimv has Invested in Apraxon Turkchem.net

BioMed, Fintech Gimv back Histogenics - - Global Corporate Venturing

BioMed, Fintech Gimv back Histogenics - Global Corporate Venturing

Gimv goes Dutch - Buyouts

Gimv goes Dutch Buyouts

Gimv and Top Brands take majority shareholding in Ellis Gourmet Burger - The Brussels Times

Gimv and Top Brands take majority shareholding in Ellis Gourmet Burger The Brussels Times

SpineArt Secures CHF 25 Million Investment from Gimv and EGS Beteiligungen to Accelerate Global Growth - Global Legal Chronicle

SpineArt Secures CHF 25 Million Investment from Gimv and EGS Beteiligungen to Accelerate Global Growth Global Legal Chronicle

Top Gimv Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant